Please select the option that best describes you:
Would you consider using a JAK inhibitor for a patient with RA associated scleritis?
Patient previously trialed two anti-TNFi and Tocilizumab. Avoiding Rituximab due to positive JC virus testing.
Answer from: at Academic Institution
Yes, I have used it before with success when with limited options. I recommend speaking to the MSL from one of the JAKi developers and they can provide the data to make an informed decision or to appeal to insurance if denied.
Sign in or Register to read more
Answer from: at Academic Institution
Absolutely, especially when the patient failed TNF and actemra, has contraindication to rituxan. Just not sure what +test here for JC virus.
Comments
at Hill Country Dermatology
There is decent anecdotal literature on use of JAK...
There is decent anecdotal literature on use of JAK...